Servier has been serving patients across the Middle East since 1977, driven by a long-standing commitment to therapeutic innovation and patient care.

Today, Servier Middle East operates in Bahrain, Jordan, Kuwait, the Kingdom of Saudi Arabia, Oman, Qatar, the United Arab Emirates, and Egypt (Oncology operations). Our regional offices are based in the United Arab Emirates and the Kingdom of Saudi Arabia, supporting operations across the region and ensuring close collaboration with healthcare stakeholders and partners.

Supported by a team of 160 passionate employees, we are united by a common purpose: committed to therapeutic progress to serve patient needs. What makes Servier different, and what makes us strong, is our unique governance model. Governed by a foundation, enabling the Group to take a long-term approach and sustainably reinvest its resources into research, innovation, and patient care. This independence allows us to remain fully focused on discovering and delivering innovative therapeutic solutions that make a meaningful difference in patients’ lives.

Servier concentrates its research and development efforts in areas where unmet medical needs remain significant. In the Middle East, our focus spans three key therapeutic areas:

  • Oncology
  • Neurology
  • Cardio metabolism & Venous Diseases

Across the Middle East, we remain dedicated to advancing healthcare outcomes by providing innovative treatments and supporting healthcare professionals in addressing the region’s evolving medical needs.